SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that it will present more than 30 abstracts across more than 10 cancer types at the European Society for Medical Oncology (ESMO) Congress 2025, held October 17-21, 2025 in Berlin, Germany. The data underscore Genentech’s commitment to … [Read more…]
The Centre for Asian Philanthropy and Society research examines unique approaches by domestic funders in China, India, Indonesia, and the Philippines as the landscape for overseas development assistance shifts HONG KONG–(BUSINESS WIRE)–New research from the Centre for Asian Philanthropy and Society (CAPS) highlights how the withdrawal of United States and other overseas development assistance is … [Read more…]
Six oral presentations highlight Signatera’s expanding role across solid tumors, including definitive predictive data in adjuvant bladder cancer AUSTIN, Texas–(BUSINESS WIRE)–Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that 14 studies featuring its technology will be presented at the European Society for Medical Oncology (ESMO) Congress, taking place … [Read more…]
TORONTO–(BUSINESS WIRE)–Yesterday, Ontario Health at Home announced that it was reconsidering the timeline for its four-day-a-week return-to-office plan — a clear response to the growing pressure from CUPE members who spoke out together. But less than 24 hours later, at 2 p.m. today, the employer issued another memo reversing course and announcing that staff will … [Read more…]
CRANBURY, N.J.–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that on October 6, 2025, the Compensation Committee of Rocket’s Board of Directors approved the grant of inducement equity incentive awards to its newly-hired Chief Medical … [Read more…]
Launch of new healthcare plan for dual-eligible members of Medi-Cal and Medicare Enrollment begins October 15 SANTA BARBARA, Calif.–(BUSINESS WIRE)–#ACA–This week CenCal Health announced the launch of CenCal CareConnect, a new Medicare Advantage health plan designed to make healthcare simpler for people who qualify for both Medicare and Medi-Cal. Enrollment for the new plan begins … [Read more…]
ARLINGTON, Va.–(BUSINESS WIRE)–Leonardo DRS, Inc. (NASDAQ: DRS) announced today it will mark its seventh year of supporting the “Stick It to Cancer” fundraiser at the 2025 AUSA Annual Meeting & Exposition in Washington, D.C., recognizing Breast Cancer Awareness Month and supporting military members and families affected by breast cancer. As part of this ongoing initiative, … [Read more…]
ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, will host an Investor Day at the Company’s Acton, Massachusetts headquarters on Thursday, November 20, 2025. The Investor Day will include presentations from the management team highlighting the Company’s longer-term strategic … [Read more…]
Results presented today at ESGCT 2025 PARIS–(BUSINESS WIRE)–Genethon, a worldwide pioneer and leader in research and development of gene therapy for rare genetic diseases, and Hansa Biopharma, a Sweden-based leader in IgG cleaving enzyme technology announced today that a patient with a rare liver disease and immunity to the AAV vector has been successfully treated … [Read more…]
Analysis shows statistically significant survival benefit in individuals with infantile-onset Niemann-Pick disease type C (NPC) treated with adrabetadex compared to matched external controls Findings from an analysis of key biomarkers support the disease-modifying potential of adrabetadex in individuals with NPC THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Mandos Health® by Beren Therapeutics Public Benefit Corporation (P.B.C.) announced today that … [Read more…]
